Conceivable Life Sciences is a startup.
Conceivable Life Sciences develops AURA, an automation-assisted IVF lab that combines precision robotics, advanced optics and proprietary software to automate embryology workflows and improve IVF outcomes. The system generates standardized process data, is being validated in an IRB-approved clinical study, and the company reports over 30 live births and more than 60 pregnancies to date.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.